Ambic Aayurchem Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 2.87 Cr
as on 08-07-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.25 Cr
as on 08-07-2024
- Satisfied Charges ₹ 7.20 Cr
as on 08-07-2024
- Revenue 593.09%
(FY 2023)
- Profit -174.14%
(FY 2023)
- Ebitda -276.12%
(FY 2023)
- Net Worth -3.54%
(FY 2023)
- Total Assets 0.09%
(FY 2023)
About Ambic Aayurchem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.87 Cr.
The company currently has active open charges totaling ₹1.25 Cr. The company has closed loans amounting to ₹7.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shanker Gupta, Deepak Sharma, and Takshshila serve as directors at the Company.
- CIN/LLPIN
U24232UR2005PLC029735
- Company No.
029735
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Roorkee, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ambic Aayurchem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanker Gupta  | Director | 01-Mar-2015 | Current |
| Deepak Sharma | Director | 08-Jul-2022 | Current |
| Takshshila | Director | 28-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Ambic Aayurchem.
Ambic Aayurchem Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 593.09% increase. The company also saw a substantial fall in profitability, with a 174.14% decrease in profit. The company's net worth dipped by a decrease of 3.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ambic Aayurchem?
In 2023, Ambic Aayurchem had a promoter holding of 65.74% and a public holding of 34.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jan 2018 | ₹1.25 Cr | Open |
Punjab National Bank Creation Date: 12 Jan 2008 | ₹3.60 Cr | Satisfied |
Punjab National Bank Creation Date: 11 Jan 2008 | ₹3.60 Cr | Satisfied |
How Many Employees Work at Ambic Aayurchem?
Ambic Aayurchem has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ambic Aayurchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ambic Aayurchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
